Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)

NCT07218172 · clinicaltrials.gov ↗
COMPLETED
Status
197
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca